|
|
|
@ -42,4 +42,7 @@ date:: [[2023/12]]
|
|
|
|
|
- Ghana
|
|
|
|
|
- Kenya
|
|
|
|
|
- ### WP 4 - Acceptability & adherence & feasability - Ivy leads
|
|
|
|
|
- Target protocol implementation: end 2024 or
|
|
|
|
|
- Target protocol implementation: end 2024 or early 2025 (rainy season permitting) for implementation.
|
|
|
|
|
- Standalone; not part of the Safety and Effectiveness clinical trial
|
|
|
|
|
- Protocol
|
|
|
|
|
- January: Draft primary and secondary research questions aligned to government/programme decision
|